s20098 has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bomsel, M; Cecon, E; Dam, J; Ghigna, MR; Izabelle, C; Jockers, R; Klonjkowski, B; Poder, SL; Real, F; Tu, L; Zhu, A | 1 |
| Uvais, NA | 1 |
2 other study(ies) available for s20098 and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Therapeutic potential of melatonin and melatonergic drugs on K18-hACE2 mice infected with SARS-CoV-2.
Topics: Acetamides; Animals; COVID-19; COVID-19 Drug Treatment; Indenes; Lung; Melatonin; Mice; Mice, Inbred C57BL; Mice, Transgenic; SARS-CoV-2; Viral Load | 2022 |
Psychological Impact of the COVID-19 Pandemic Among the Elderly: A Case Series From India.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents; Betacoronavirus; Citalopram; Clonazepam; Coronavirus Infections; COVID-19; Depressive Disorder; Female; Humans; India; Lorazepam; Male; Mirtazapine; Pandemics; Panic Disorder; Pneumonia, Viral; SARS-CoV-2 | 2020 |